SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) Short Interest Down 37.8% in March

SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) was the target of a large decline in short interest in March. As of March 13th, there was short interest totaling 383,310 shares, a decline of 37.8% from the February 26th total of 616,003 shares. Currently, 7.4% of the company’s stock are sold short. Based on an average trading volume of 94,254 shares, the days-to-cover ratio is currently 4.1 days.

Institutional Investors Weigh In On SPDR S&P Pharmaceuticals ETF

A number of large investors have recently modified their holdings of XPH. Envestnet Asset Management Inc. purchased a new stake in shares of SPDR S&P Pharmaceuticals ETF during the 3rd quarter valued at about $10,732,000. LPL Financial LLC lifted its position in SPDR S&P Pharmaceuticals ETF by 13.2% during the 4th quarter. LPL Financial LLC now owns 207,649 shares of the company’s stock worth $11,630,000 after acquiring an additional 24,252 shares in the last quarter. Wells Fargo & Company MN boosted its holdings in SPDR S&P Pharmaceuticals ETF by 175.6% in the 4th quarter. Wells Fargo & Company MN now owns 207,229 shares of the company’s stock worth $11,607,000 after acquiring an additional 132,037 shares during the period. First Citizens Bank & Trust Co. boosted its holdings in SPDR S&P Pharmaceuticals ETF by 2.5% in the 4th quarter. First Citizens Bank & Trust Co. now owns 186,004 shares of the company’s stock worth $10,418,000 after acquiring an additional 4,575 shares during the period. Finally, Envestnet Portfolio Solutions Inc. grew its position in SPDR S&P Pharmaceuticals ETF by 2.0% in the fourth quarter. Envestnet Portfolio Solutions Inc. now owns 175,309 shares of the company’s stock valued at $9,819,000 after acquiring an additional 3,379 shares in the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Performance

SPDR S&P Pharmaceuticals ETF stock traded down $1.11 during trading on Friday, reaching $52.28. 8,469 shares of the company’s stock were exchanged, compared to its average volume of 102,939. SPDR S&P Pharmaceuticals ETF has a 52-week low of $35.22 and a 52-week high of $58.84. The firm has a market cap of $271.86 million, a price-to-earnings ratio of 14.28 and a beta of 0.60. The company’s 50-day moving average is $55.93 and its two-hundred day moving average is $53.03.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.